224 related articles for article (PubMed ID: 19338453)
1. Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life.
Silva MJ; Brodt MD; Lynch MA; McKenzie JA; Tanouye KM; Nyman JS; Wang X
J Bone Miner Res; 2009 Sep; 24(9):1618-27. PubMed ID: 19338453
[TBL] [Abstract][Full Text] [Related]
2. Amylin and bone metabolism in streptozotocin-induced diabetic rats.
Horcajada-Molteni MN; Chanteranne B; Lebecque P; Davicco MJ; Coxam V; Young A; Barlet JP
J Bone Miner Res; 2001 May; 16(5):958-65. PubMed ID: 11341342
[TBL] [Abstract][Full Text] [Related]
3. Dietary xylitol supplementation prevents osteoporotic changes in streptozotocin-diabetic rats.
Mattila PT; Knuuttila ML; Svanberg MJ
Metabolism; 1998 May; 47(5):578-83. PubMed ID: 9591750
[TBL] [Abstract][Full Text] [Related]
4. DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats.
Glorie L; Behets GJ; Baerts L; De Meester I; D'Haese PC; Verhulst A
Am J Physiol Endocrinol Metab; 2014 Sep; 307(5):E447-55. PubMed ID: 25053403
[TBL] [Abstract][Full Text] [Related]
5. Skeletal changes in type-2 diabetic Goto-Kakizaki rats.
Ahmad T; Ohlsson C; Sääf M; Ostenson CG; Kreicbergs A
J Endocrinol; 2003 Jul; 178(1):111-6. PubMed ID: 12844342
[TBL] [Abstract][Full Text] [Related]
6. Osteopenia: a bone disorder associated with diabetes mellitus.
Duarte VM; Ramos AM; Rezende LA; Macedo UB; Brandão-Neto J; Almeida MG; Rezende AA
J Bone Miner Metab; 2005; 23(1):58-68. PubMed ID: 15616896
[TBL] [Abstract][Full Text] [Related]
7. Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress.
Hamada Y; Kitazawa S; Kitazawa R; Fujii H; Kasuga M; Fukagawa M
Bone; 2007 May; 40(5):1408-14. PubMed ID: 17251074
[TBL] [Abstract][Full Text] [Related]
8. Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone.
Nyman JS; Even JL; Jo CH; Herbert EG; Murry MR; Cockrell GE; Wahl EC; Bunn RC; Lumpkin CK; Fowlkes JL; Thrailkill KM
Bone; 2011 Apr; 48(4):733-40. PubMed ID: 21185416
[TBL] [Abstract][Full Text] [Related]
9. Eldecalcitol, an Active Vitamin D
Takeda S; Saito M; Sakai S; Yogo K; Marumo K; Endo K
Calcif Tissue Int; 2017 Oct; 101(4):433-444. PubMed ID: 28624935
[TBL] [Abstract][Full Text] [Related]
10. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
[TBL] [Abstract][Full Text] [Related]
11. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
[TBL] [Abstract][Full Text] [Related]
12. Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats.
Bain S; Ramamurthy NS; Impeduglia T; Scolman S; Golub LM; Rubin C
Bone; 1997 Aug; 21(2):147-53. PubMed ID: 9267690
[TBL] [Abstract][Full Text] [Related]
13. Brittle bones in spontaneously diabetic female rats cannot be predicted by bone mineral measurements: studies in diabetic and ovariectomized rats.
Verhaeghe J; Suiker AM; Einhorn TA; Geusens P; Visser WJ; Van Herck E; Van Bree R; Magitsky S; Bouillon R
J Bone Miner Res; 1994 Oct; 9(10):1657-67. PubMed ID: 7817814
[TBL] [Abstract][Full Text] [Related]
14. Degradation of bone structural properties by accumulation and coalescence of microcracks.
Danova NA; Colopy SA; Radtke CL; Kalscheur VL; Markel MD; Vanderby R; McCabe RP; Escarcega AJ; Muir P
Bone; 2003 Aug; 33(2):197-205. PubMed ID: 14499353
[TBL] [Abstract][Full Text] [Related]
15. Moderate-intensity 4mT static magnetic fields prevent bone architectural deterioration and strength reduction by stimulating bone formation in streptozotocin-treated diabetic rats.
Zhang H; Gan L; Zhu X; Wang J; Han L; Cheng P; Jing D; Zhang X; Shan Q
Bone; 2018 Feb; 107():36-44. PubMed ID: 29111170
[TBL] [Abstract][Full Text] [Related]
16. Bone formation after damaging in vivo fatigue loading results in recovery of whole-bone monotonic strength and increased fatigue life.
Silva MJ; Touhey DC
J Orthop Res; 2007 Feb; 25(2):252-61. PubMed ID: 17106875
[TBL] [Abstract][Full Text] [Related]
17. Changes in the Fracture Resistance of Bone with the Progression of Type 2 Diabetes in the ZDSD Rat.
Creecy A; Uppuganti S; Merkel AR; O'Neal D; Makowski AJ; Granke M; Voziyan P; Nyman JS
Calcif Tissue Int; 2016 Sep; 99(3):289-301. PubMed ID: 27209312
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term diabetes and/or high-dose 17 beta-estradiol on bone formation, bone mineral density, and strength in ovariectomized rats.
Verhaeghe J; Oloumi G; van Herck E; van Bree R; Dequeker J; Einhorn TA; Bouillon R
Bone; 1997 May; 20(5):421-8. PubMed ID: 9145239
[TBL] [Abstract][Full Text] [Related]
19. Exercise initiated after the onset of insulin resistance improves trabecular microarchitecture and cortical bone biomechanics of the tibia in hyperphagic Otsuka Long Evans Tokushima Fatty rats.
Ortinau LC; Linden MA; Dirkes RK; Rector RS; Hinton PS
Bone; 2017 Oct; 103():188-199. PubMed ID: 28711659
[TBL] [Abstract][Full Text] [Related]
20. L-arginine supplementation normalizes bone turnover and preserves bone mass in streptozotocin-induced diabetic rats.
Pennisi P; Clementi G; Prato A; Luca T; Martinez G; Mangiafico RA; Pulvirenti I; Muratore F; Fiore CE
J Endocrinol Invest; 2009 Jun; 32(6):546-51. PubMed ID: 19494718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
